In the competitive and costly landscape of pharmaceutical development, identifying viable drug targets early in the R&D pipeline is both a scientific challenge and a financial imperative. Predictive analytics—a powerful convergence of data science, machine learning (ML), and biomedical research—is revolutionizing early-stage drug discovery by